BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35778921)

  • 1. Patient reporting of sexual adverse events on an online platform for medication experiences.
    Gordijn R; Wessels W; Kriek E; Nicolai MPJ; Elzevier HW; Visser L; Guchelaar HJ; Teichert M
    Br J Clin Pharmacol; 2022 Dec; 88(12):5326-5335. PubMed ID: 35778921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles.
    Tang E; Ravaud P; Riveros C; Perrodeau E; Dechartres A
    BMC Med; 2015 Aug; 13():189. PubMed ID: 26269118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting.
    Trenque T; Maura G; Herlem E; Vallet C; Sole E; Auriche P; Drame M
    Drug Saf; 2013 Jul; 36(7):515-9. PubMed ID: 23728950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study.
    Hughes S; Cohen D; Jaggi R
    BMJ Open; 2014 Jul; 4(7):e005535. PubMed ID: 25009136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database.
    Matsuoka Y; Narukawa M
    Ther Innov Regul Sci; 2018 May; 52(3):339-347. PubMed ID: 29714536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
    Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
    J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide pharmacovigilance investigation on trends and seriousness of adverse events induced by anti-obesity medication.
    Choi YJ; Choi CY; Kim CU; Shin S
    J Glob Health; 2023 Sep; 13():04095. PubMed ID: 37651636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
    Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
    Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?
    Olivier P; Gimbert A; Colin AL; Salvo F; Becker M; Marty V; Montastruc JL; Petitpain N
    Br J Clin Pharmacol; 2016 Oct; 82(4):1069-75. PubMed ID: 27276241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase.
    Vabre C; Johnson K; Montastruc F; Vezzosi D; Yu OH; Renoux C
    Eur J Clin Pharmacol; 2023 Mar; 79(3):383-388. PubMed ID: 36602591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database.
    Niinomi I; Oyama S; Inada A; Wakabayashi T; Hirai T; Kambara H; Iida T; Uchida M; Sano Y; Hosohata K
    Int J Clin Pharmacol Ther; 2022 Sep; 60(9):402-407. PubMed ID: 35924642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.
    Andreaggi CA; Novak EA; Mirabile ME; Sampathkumar S; Gray MP; He M; Kane-Gill SL
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1627-1635. PubMed ID: 32851782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.
    Chen JJ; Huo XC; Wang SX; Wang F; Zhao Q
    Int J Clin Pharm; 2022 Dec; 44(6):1351-1360. PubMed ID: 36178607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the causality assessment of adverse events following immunisation in paediatric clinical trials: An online survey.
    Voysey M; Tavana R; Farooq Y; Heath PT; Bonhoeffer J; Snape MD
    Vaccine; 2015 Dec; 33(51):7203-7210. PubMed ID: 26552002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
    Janjua S; Schmidt S; Ferrer M; Cates CJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons.
    Pietraszkiewicz E; Firlag-Burkacka E; Horban A; Kowalska JD
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19733. PubMed ID: 25397479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
    de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
    Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.